Osteoarthritis News and Research

Latest Osteoarthritis News and Research

Study examines how opioid overdose differs by prescribed dose for chronic pain conditions

More and more Americans with chronic pain not caused by cancer are taking medically prescribed opioids like Oxycontin (oxycodone) and Vicodin (hydrocodone). The January 19 Annals of Internal Medicine features the first study to explore the risk of overdose in patients prescribed opioids for chronic noncancer pain in general health care.

19 Jan 2010

Sunlight and vitamin D deficiency linked to 17 varieties of cancer

For humans, sunlight and vitamin D is critically important for the development, growth, and maintenance of a healthy body, from birth until death. "Humans make thousands of units of vitamin D within minutes of whole body exposure to sunlight. From what we know of nature, it is unlikely such a system evolved by chance," states Dr. John Cannell, Executive Director, Vitamin D Council.

18 Jan 2010

Massage, manipulation and other hands-on approaches can reduce chronic pain

The January issue of Mayo Clinic Women's HealthSource discusses the uses and benefits of massage, spinal manipulation, and Rolfing, as well as the Alexander technique and the Feldenkrais method

18 Jan 2010

Soccer-specific exercise program may prevent knee injuries in young female players

A soccer-specific exercise program that includes individual instruction of athletes appears to reduce the risk of knee injuries in young female players, according to a report in the January 11 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

12 Jan 2010

NicOx, TOPIGEN Pharmaceuticals terminate TPI 1020 collaboration

NicOx S.A. today announced that NicOx and TOPIGEN Pharmaceuticals Inc. have mutually terminated their collaboration for TPI 1020. This decision was made as a result of the acquisition of TOPIGEN by Pharmaxis announced yesterday.

12 Jan 2010

Study finds self-management alone may effectively treat knee osteoarthritis

Researchers participating in the Multidimensional Intervention for Early Osteoarthritis of the Knee (Knee Study) determined that physically inactive, middle-aged people with symptomatic osteoarthritis benefitted equally from strength training regimens, self-management programs, or a combination of the two. Details of this study are available in the January 2010 issue of Arthritis Care & Research, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology.

6 Jan 2010

Global scientific meeting on osteoporosis and osteoarthritis

IOF WCO-ECCEO10 will be the largest global scientific meeting devoted exclusively to osteoporosis and osteoarthritis in 2010. We look forward to welcoming you in Florence next spring!

5 Jan 2010

Study shows running shoes exert greater stress on knees, hips and ankles

Knee osteoarthritis (OA) accounts for more disability in the elderly than any other disease. Running, although it has proven cardiovascular and other health benefits, can increase stresses on the joints of the leg.

5 Jan 2010

Study shows low postoperative mortality rates after hip and knee replacement surgeries

Total hip and total knee replacement surgeries are highly successful and very common procedures for people experiencing pain associated with degenerative joints.

5 Jan 2010

Anika Therapeutics acquires Fidia Farmaceutici subsidiary FAB

Anika Therapeutics, Inc. today announced that it has acquired Fidia Advanced Biopolymers, s.r.l. (“FAB”), a wholly-owned subsidiary of privately held Italian pharmaceutical company, Fidia Farmaceutici S.p.A. FAB provides hyaluronic acid-based (“HA”) products in several therapeutic areas including for the regeneration of connective and structural tissues damaged by injuries, aging or degenerative diseases.

3 Jan 2010

Health and education leaders commend school for promoting physical activity among students

During a visit today to Conrad Weiser Middle School, Department of Health Secretary Everette James and Secretary of Education Gerald Zahorchak commended the school for its efforts to increase physical activity among students.

22 Dec 2009

Emisphere's oral salmon calcitonin product addresses persistent musculoskeletal pain

Emisphere Technologies, Inc. today announced a meta-analysis published in the December 2009 edition of Rheumatology Reports examining independent evidence of the analgesic action of the hormone calcitonin. This publication restates the potential of calcitonin in filling a significant unmet need for alternative treatments for persistent musculoskeletal pain.

22 Dec 2009

MAA for naproxcinod submitted to EMEA through centralized procedure

NicOx S.A. today announced that a Marketing Authorization Application (MAA) for naproxcinod has been submitted to the European Medicines Agency (EMEA) through the centralized procedure, seeking approval for an indication for the relief of the signs and symptoms of osteoarthritis (OA).

22 Dec 2009

New minimally invasive orthopedic knee procedure brought to San Antonio

Foundation Surgical Hospital of San Antonio today announced it has brought MAKOplasty®, a minimally invasive orthopedic knee procedure, to San Antonio.

22 Dec 2009

InHealth to further understand socioeconomic impact of medical devices and diagnostics

As the Institute for Health Technology Studies (InHealth) marks its five-year milestone, the research and educational nonprofit is taking stock of its contributions to objective evidence about the roles that medical technologies play in the economy, in the healthcare system, and in patients' lives.

19 Dec 2009

Unigene Laboratories selects UGP281 lead peptide from obesity program for development

Unigene Laboratories, Inc. (http://www.unigene.com) announced today that it has selected a lead peptide compound, designated UGP281, from its obesity program for development.

18 Dec 2009

Roche's P2X3 receptor program for chronic pain licensed to Afferent Pharmaceuticals

Roche announced today it has licensed its P2X3 receptor program aimed at developing first-in-class treatments for chronic pain to Afferent Pharmaceuticals. Afferent was co-founded by Anthony Ford, Ph.D., Pappas Ventures, and Third Rock Ventures, and is focused on developing compounds that treat chronic pain by targeting a novel biological pathway.

16 Dec 2009

Innovative approaches to develop more effective interventions to reduce obesity

The National Institutes of Health is launching a $37 million program that will use findings from basic research on human behavior to develop more effective interventions to reduce obesity.

13 Dec 2009

Oconomowoc Memorial Hospital performs partial knee resurfacing surgery using MAKOplasty technology

For the first time in Wisconsin, patients suffering from arthritis pain have access to a new procedure that uses the precision of robotics to perform partial knee resurfacing surgery. The technology, called MAKOplasty®, is a minimally invasive surgical option that results in shorter hospital stays and faster healing than traditional knee surgeries.

11 Dec 2009

NIH launches a $37 million program to reduce obesity

The National Institutes of Health is launching a $37 million program that will use findings from basic research on human behavior to develop more effective interventions to reduce obesity.

11 Dec 2009

Osteoarthritis News and Research

Latest Osteoarthritis News and Research

Study examines how opioid overdose differs by prescribed dose for chronic pain conditions

Sunlight and vitamin D deficiency linked to 17 varieties of cancer

Massage, manipulation and other hands-on approaches can reduce chronic pain

Soccer-specific exercise program may prevent knee injuries in young female players

NicOx, TOPIGEN Pharmaceuticals terminate TPI 1020 collaboration

Study finds self-management alone may effectively treat knee osteoarthritis

Global scientific meeting on osteoporosis and osteoarthritis

Study shows running shoes exert greater stress on knees, hips and ankles

Study shows low postoperative mortality rates after hip and knee replacement surgeries

Anika Therapeutics acquires Fidia Farmaceutici subsidiary FAB

Health and education leaders commend school for promoting physical activity among students

Emisphere's oral salmon calcitonin product addresses persistent musculoskeletal pain

MAA for naproxcinod submitted to EMEA through centralized procedure

New minimally invasive orthopedic knee procedure brought to San Antonio

InHealth to further understand socioeconomic impact of medical devices and diagnostics

Unigene Laboratories selects UGP281 lead peptide from obesity program for development

Roche's P2X3 receptor program for chronic pain licensed to Afferent Pharmaceuticals

Innovative approaches to develop more effective interventions to reduce obesity

Oconomowoc Memorial Hospital performs partial knee resurfacing surgery using MAKOplasty technology

NIH launches a $37 million program to reduce obesity

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Osteoarthritis News and Research

Latest Osteoarthritis News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in